论文部分内容阅读
前列腺癌是伴随男性衰老而发生的一种常见疾病,在50岁以上的男性人群中,其发病率随年龄而增长。其死亡率在男性肿瘤中居第二。该病的早期诊断和早期治疗效果将非常明显。因此寻找灵敏和特异的诊断方法是十分有意义的。前列腺酸性磷酸酶(prostate acid phosphatase,PAP)和前列腺特异性抗原(prostate specific antigen,PSA)在前列腺癌诊断和筛选是十分有用的,是二个非常理想的血清学诊断指标。本文将对我院就诊的132位患前列腺疾病的病人进行测定血清PAP和PSA来探讨其在前列腺癌中的诊断价值,现报道如下。
Prostate cancer is a common disease that occurs with the aging of men. In the male population over the age of 50, the incidence increases with age. Its mortality rate ranks second among male tumors. The early diagnosis and early treatment of the disease will be very effective. Therefore, it is very meaningful to search for sensitive and specific diagnostic methods. Prostate acid phosphatase (PAP) and prostate specific antigen (PSA) are very useful in the diagnosis and screening of prostate cancer. They are two very good serological diagnostic indicators. This article will be 132 patients with prostate disease in our hospital for the treatment of patients with prostate disease measured serum PAP and PSA to explore its diagnostic value in prostate cancer, are reported below.